Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Effectiveness of Shared Decision Making(SDM)on Patients With Poor Control Type 2 Diabetes (SDM)

4 september 2026 uppdaterad av: Fooyin University
The study is a pilot study, using a convenient sampling method, targeting at outpatient patients with type 2 diabetes who participate in the diabetes co-care program and poor blood sugar control as the research subjects, and randomly assigned. The number of samples is expected to receive 30 patients in each group. The attrition rate estimates about 20%, so there should be 76 people in total, and 38 people in each group. The experimental group was involved in SDM health education; the control group was involved in routine health education. After the implementation of the measures, the self-efficacy and health promotion behavior changes of the two groups and the effectiveness of disease control (glycated hemoglobin, body mass index, waist circumference) were tracked.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

Background Diabetes and hyperglycemia not only increase the risk of complications of cardiovascular disease and lead to a situation involving exposure to danger of death. Meanwhile, the patient's self-management is one of the key factors affecting the quality control of blood sugar. Thereby, Shared Decision Making (SDM) is a patient-centered medical implementation method that healthcare professionals and patients jointly participate in treatment decision-making to reach a consensus, which can stimulate the health care ability of participants to achieve treatment goals.

Purpose: This research aims to implement the SDM model based on self-efficacy theory through individualized decision-making to strengthen the behavioral motivation of diabetic patients and finally, to improve the patient's health promotion behavior and the effectiveness of blood sugar control.

Method: Study Type: Interventional Actual Enrollment:76 participants Allocation:Randomized Intervention Model:Parallel Assignment Masking:Single(Participant)

Expected results:

It is hoped that the implementation of SDM model will be used to strengthen the behavioral motivation of diabetic patients through individualized decision-making, and to confirm whether it can effectively improve the patient's health behavior and the effectiveness of disease control.

Studietyp

Interventionell

Inskrivning (Faktisk)

70

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Taiwan
      • Tainan, Taiwan, Taiwan, 709204
        • An Nan Hospition-China Medical University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  • Aged>20y/o
  • Diagnosed by a physician as type 2 diabetes
  • The Diabetes Participated in the Diabetes Shared Care Network
  • Glycosylated hemoglobin (A1C)> 7.5%
  • Can communicate in Chinese or Taiwanese.

Exclusion Criteria:

  • People with mental or cognitive impairment who cannot communicate
  • Health Literacy score lower than 6 points

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Inget ingripande: Control group:as usual care
The control group received as usual care.
Experimentell: Experimental group:The intervention of SDM
The experimental group received the intervention of SDM 3 times for 3 months,
The experimental group received the intervention of SDM 3times/month for 3months, then follow the health promotion behavior compliance by phone once a month.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Diabetes self-efficacy scale
Tidsram: Pre-test (baseline)
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
Pre-test (baseline)
Diabetes self-efficacy scale
Tidsram: 1 months after intervnetion
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
1 months after intervnetion
Diabetes self-efficacy scale
Tidsram: 3 months after intervnetion
assesses the confidence of diabetes patients in their ability to manage their diet, blood sugar, and physical exercise
3 months after intervnetion
Diabetes health literacy scale
Tidsram: Pre-test (baseline)
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
Pre-test (baseline)
Diabetes health literacy scale
Tidsram: 3 months after intervnetion
A disease-specific scale to measure functional, communicative and critical health literacy in primary care
3 months after intervnetion
Diabetes health promotion scale
Tidsram: Pre-test (baseline)
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
Pre-test (baseline)
Diabetes health promotion scale
Tidsram: 1 months after intervnetion
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
1 months after intervnetion
Diabetes health promotion scale
Tidsram: 3 months after intervnetion
A self-report study instrument that includes the health profile, and Diabetes Health Promotion Scale
3 months after intervnetion
Hemoglobin A1C (HbA1c) Test
Tidsram: 3 months after intervnetion
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months.
3 months after intervnetion
Hemoglobin A1C (HbA1c) Test
Tidsram: Pre-test (baseline)
An HbA1c test shows what the average amount of glucose attached to hemoglobin has been over the past three months
Pre-test (baseline)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

12 maj 2020

Primärt slutförande (Faktisk)

30 oktober 2020

Avslutad studie (Faktisk)

30 juni 2021

Studieregistreringsdatum

Först inskickad

14 mars 2022

Först inskickad som uppfyllde QC-kriterierna

4 september 2026

Första postat (Faktisk)

9 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

9 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

4 september 2026

Senast verifierad

1 september 2021

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera